2026-06-14T03:32:10Zhttps://repisalud.isciii.es/rest/oai/requestoai:repisalud.isciii.es:20.500.12105/201002024-11-28T20:47:30Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16967
00925njm 22002777a 4500
dc
Gayoso, Jorge
author
Balsalobre, Pascual
author
Kwon, Mi
author
Sampol Mayol, Antonia
author
Montesinos, Pau
author
Serrano, David
author
Herrera, Pilar
author
Jesus Pascual, Maria
author
Bermudez, Arancha
author
Castilla-Llorente, Cristina
author
Bento, Leyre
author
Champ, Diana
author
Perez-Corral, Ana
author
Buces, Elena
author
Luis Diez-Martin, Jose
author
2015-02
Gayoso J, Balsalobre P, Kwon M, Sampol A, Montesinos P, Serrano D, et al. Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As GVHD Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS) [meeting abstract]. Biol Blood Marrow Transplant. 2015 Feb;21(Suppl 2):S186.
10.1016/j.bbmt.2014.11.283
1523-6536
1083-8791
Biology of Blood and Marrow Transplantation
http://hdl.handle.net/20.500.13003/17323
http://hdl.handle.net/20.500.12105/20100
348633000245
Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As GVHD Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS)